Mackenzie Financial Corp Royalty Pharma PLC Transaction History

Mackenzie Financial Corp

$77.1 Billion
Q3 2025

A detailed history of Mackenzie Financial Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Mackenzie Financial Corp holds 49,444 shares of RPRX stock, worth $1.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,444

Previous 68,242 27.55%

Holding current value

$1.94 Million

Previous $2.46 Million 29.05%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$34.9 - $37.91 $656,050 - $712,632	-18,798 Reduced 27.55%	49,444 $1.74 Million
Q2 2025 Aug 13, 2025	SELL	$30.85 - $36.14 $8.61 Million - $10.1 Million	-279,136 Reduced 80.36%	68,242 $2.46 Million
Q1 2025 May 07, 2025	BUY	$25.75 - $33.86 $5.29 Million - $6.95 Million	205,356 Added 144.59%	347,378 $10.8 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $226,119 - $264,396	9,313 Added 7.02%	142,022 $3.62 Million
Q3 2024 Nov 13, 2024	BUY	$25.63 - $29.27 $3.15 Million - $3.6 Million	123,066 Added 1276.22%	132,709 $3.75 Million

Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $492,164 - $560,385	-18,742 Reduced 66.03%	9,643 $254,000
Q1 2024 May 10, 2024	SELL	$27.46 - $31.33 $2.31 Million - $2.63 Million	-84,058 Reduced 74.76%	28,385 $862,000
Q4 2023 Jan 30, 2024	BUY	$26.21 - $29.22 $2.42 Million - $2.7 Million	92,372 Added 460.23%	112,443 $3.16 Million
Q3 2023 Oct 25, 2023	SELL	$26.26 - $31.38 $9,112 - $10,888	-347 Reduced 1.7%	20,071 $544,000
Q2 2023 Aug 03, 2023	SELL	$29.6 - $36.56 $28,534 - $35,243	-964 Reduced 4.51%	20,418 $627,000
Q1 2023 Apr 24, 2023	BUY	$32.77 - $39.4 $700,688 - $842,450	21,382 New	21,382 $770,000
Q3 2022 Oct 07, 2022	SELL	$39.88 - $44.65 $82,910 - $92,827	-2,079 Reduced 10.86%	17,065 $686,000
Q2 2022 Aug 10, 2022	BUY	$37.53 - $44.22 $718,474 - $846,547	19,144 New	19,144 $805,000
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $331,745 - $375,848	-8,856 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $692,075 - $835,921	-19,678 Reduced 68.96%	8,856 $353,000
Q3 2021 Nov 08, 2021	BUY	$36.14 - $42.24 $131,332 - $153,500	3,634 Added 14.59%	28,534 $1.03 Million
Q4 2020 Feb 10, 2021	BUY	$36.12 - $50.05 $899,387 - $1.25 Million	24,900 New	24,900 $1.25 Million

Others Institutions Holding RPRX

# of Institutions

535

Shares Held

303M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Royalty Pharma PLC Transaction History